Cargando…

CAR T-Cells Depend on the Coupling of NADH Oxidation with ATP Production

The metabolic milieu of solid tumors provides a barrier to chimeric antigen receptor (CAR) T-cell therapies. Excessive lactate or hypoxia suppresses T-cell growth, through mechanisms including NADH buildup and the depletion of oxidized metabolites. NADH is converted into NAD(+) by the enzyme Lactoba...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garcia-Canaveras, Juan C., Heo, David, Trefely, Sophie, Leferovich, John, Xu, Chong, Philipson, Benjamin I., Ghassemi, Saba, Milone, Michael C., Moon, Edmund K., Snyder, Nathaniel W., June, Carl H., Rabinowitz, Joshua D., O’Connor, Roddy S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472053/ https://www.ncbi.nlm.nih.gov/pubmed/34571983 http://dx.doi.org/10.3390/cells10092334

Ejemplares similares

Enhancing CAR T function with the engineered secretion of C. perfringens neuraminidase
por: Durgin, Joseph S., et al.
Publicado: (2022)

Enhancing Chimeric Antigen Receptor T Cell Anti-tumor Function through Advanced Media Design
por: Ghassemi, Saba, et al.
Publicado: (2020)

The CPT1a inhibitor, etomoxir induces severe oxidative stress at commonly used concentrations
por: O’Connor, Roddy S., et al.
Publicado: (2018)

Rapid manufacturing of non-activated potent CAR T cells
por: Ghassemi, Saba, et al.
Publicado: (2022)

Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47-mediated ‘don’t eat me signal’.
por: Liu, Mingen, et al.
Publicado: (2019)

Citius, Altius, Fortius: Performance in a Bottle for CAR T-Cells
por: Ayari, Asma, et al.
Publicado: (2020)

Humanized Chimeric Antigen Receptor (CAR) T cells
por: Kozani, Pouya Safarzadeh, et al.
Publicado: (2021)

Quantification of lactoyl-CoA (lactyl-CoA) by liquid chromatography mass spectrometry in mammalian cells and tissues
por: Varner, Erika L., et al.
Publicado: (2020)

Syntrophomonas wolfei Uses an NADH-Dependent, Ferredoxin-Independent [FeFe]-Hydrogenase To Reoxidize NADH
por: Losey, Nathaniel A., et al.
Publicado: (2017)

FluxFix: automatic isotopologue normalization for metabolic tracer analysis
por: Trefely, Sophie, et al.
Publicado: (2016)

F-actin polymerization and retrograde flow drive sustained PLCγ1 signaling during T cell activation
por: Babich, Alexander, et al.
Publicado: (2012)

Synthetic lethality of Mycobacterium tuberculosis NADH dehydrogenases is due to impaired NADH oxidation
por: Xu, Yuanyuan, et al.
Publicado: (2023)

Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent Glioblastoma
por: Durgin, Joseph S., et al.
Publicado: (2021)

Compartmentalised acyl-CoA metabolism and roles in chromatin regulation
por: Trefely, Sophie, et al.
Publicado: (2020)

A Photoenzymatic NADH Regeneration System
por: Höfler, Georg T., et al.
Publicado: (2018)

Genetic Modification of Cytokine Signaling to Enhance Efficacy of CAR T Cell Therapy in Solid Tumors
por: Ghahri-Saremi, Navid, et al.
Publicado: (2021)

Revealing the Membrane-Bound Catalytic Oxidation of NADH by the Drug Target Type-II NADH Dehydrogenase
por: Godoy-Hernandez, Albert, et al.
Publicado: (2019)

mTORC2-AKT signaling to ATP-citrate lyase drives brown adipogenesis and de novo lipogenesis
por: Martinez Calejman, C., et al.
Publicado: (2020)

A bioengineered immunocompetent human leukemia chip for preclinical screening of CAR T cell immunotherapy
por: Ma, Chao, et al.
Publicado: (2023)

Author Correction: mTORC2-AKT signaling to ATP-citrate lyase drives brown adipogenesis and de novo lipogenesis
por: Calejman, C. Martinez, et al.
Publicado: (2020)

Computational model of CAR T-cell immunotherapy dissects and predicts leukemia patient responses at remission, resistance, and relapse
por: Liu, Lunan, et al.
Publicado: (2022)

Expanding the Therapeutic Window for CAR T Cell Therapy in Solid Tumors: The Knowns and Unknowns of CAR T Cell Biology
por: Watanabe, Keisuke, et al.
Publicado: (2018)

Mycoplasma bovis NADH oxidase functions as both a NADH oxidizing and O(2) reducing enzyme and an adhesin
por: Zhao, Gang, et al.
Publicado: (2017)

Non-photosynthetic bacteria produce photocurrent mediated by NADH
por: Shlosberg, Yaniv, et al.
Publicado: (2023)

CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy
por: Rodriguez-Garcia, Alba, et al.
Publicado: (2021)

The α-Cell Conundrum: ATP-Sensitive K(+) Channels and Glucose Sensing
por: Jacobson, David A., et al.
Publicado: (2009)

Targeting PARP11 to avert immunosuppression and improve CAR T therapy in solid tumors
por: Zhang, Hongru, et al.
Publicado: (2022)

Synthesis of [4S‐(2)H]NADH, [4R‐(2)H]NADH, [4‐(2)H(2)]NADH and [4‐(2)H]NAD(+) cofactors through heterogeneous biocatalysis in heavy water
por: Rowbotham, Jack S., et al.
Publicado: (2021)

Reduction of Quinones by NADH Catalyzed by Organoiridium Complexes**
por: Liu, Zhe, et al.
Publicado: (2013)

NADH Dehydrogenases in Pseudomonas aeruginosa Growth and Virulence
por: Torres, Angela, et al.
Publicado: (2019)

Identification of the NADH-oxidase gene in Trichomonas vaginalis
por: Lamien-Meda, Aline, et al.
Publicado: (2019)

Differences in mitochondrial NADH dehydrogenase activities in trypanosomatids
por: Čermáková, Petra, et al.
Publicado: (2021)

Switching the Mechanism of NADH Photooxidation by Supramolecular Interactions
por: Mengele, Alexander K., et al.
Publicado: (2021)

NADH-Reductive Stress in Cancer Cell Proliferation
por: Choi, Dahee
Publicado: (2023)

Mutation of a distal gating residue modulates NADH binding in NADH:Quinone oxidoreductase from Pseudomonas aeruginosa PAO1
por: Moni, Bilkis Mehrin, et al.
Publicado: (2023)

Two-photon fluorescence lifetime imaging microscopy of NADH metabolism in HIV-1 infected cells and tissues
por: Snyder, Greg A., et al.
Publicado: (2023)

Investigation of NADH Binding, Hydride Transfer, and NAD(+) Dissociation during NADH Oxidation by Mitochondrial Complex I Using Modified Nicotinamide Nucleotides
por: Birrell, James A., et al.
Publicado: (2013)

Engineering enhanced CAR T-cells for improved cancer therapy
por: Milone, Michael C., et al.
Publicado: (2021)

CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
por: Pan, Kevin, et al.
Publicado: (2022)

Origin and Evolution of the Sodium -Pumping NADH: Ubiquinone Oxidoreductase
por: Reyes-Prieto, Adrian, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_l2u9o96o2kf1cek5np9jbaefmh